CheckMate 9ER offers RCC new frontline option; perspectives from the study’s principle investigator Principal InvestigatorProf. Toni Choueiri, Dana Farber Cancer Institute, Harvard University, Boston, USA TrialPhase 3, CheckMate 9ER ConferenceESMO Virtual Congress 2020 15 December 2020 15:49